Correction: The HDAC inhibitor, MPT0E028, enhances erlotinib induced cell death in EGFR-TKI-resistant NSCLC cells

• M. -C Chen,
• C. -H Chen,
• J. -C Wang,
• A. -C Tsai,
• J. -P Liou,
• S. -L Pan,
• C. -M Teng

Affiliations

M. -C Chen

Pharmacological Institute, College of Medicine, National Taiwan University

C. -H Chen

Pharmacological Institute, College of Medicine, National Taiwan University

J. -C Wang

The PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

A. -C Tsai

Pharmacological Institute, College of Medicine, National Taiwan University

J. -P Liou

School of Pharmacy, College of Pharmacy, Taipei Medical University

S. -L Pan

The PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

C. -M Teng

Pharmacological Institute, College of Medicine, National Taiwan University